Westminster Health Forum

The future for NICE in health and social care

Morning, Thursday, 6th February 2020

Glaziers Hall, 9 Montague Close, London SE1 9DD

THIS EVENT IS CPD CERTIFIED


This conference will be a timely opportunity to discuss the next steps for NICE - looking at:

  • Developing evidence-based guidelines;
  • The impact of NICE’s recommendations on decision-making; and
  • The role of NICE in accelerating the uptake of innovation.

The conference takes place in light of the publication of the Life Sciences Sector Deal 2, which committed to making additional funding available to NICE and increasing the number of evaluations of digital products by 2020.


It also follows the introduction of the Voluntary Scheme for Branded Medicines Pricing and Access, which included plans to provide faster assessments of the clinical and cost-effectiveness of new medicines.


Speakers

There will be keynote addresses from: Meindert Boysen, Director, Centre for Health Technology Evaluation, NICE and Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care, NICE.


Further confirmed speakers include: Professor Andrew Briggs, London School of Hygiene & Tropical Medicine; Professor Matthew Cripps, NHS England and NHS Improvement.


Dr Alan MacDonald, Scottish Medicines Consortium; Hilary Hutton-Squire, Gilead and Doris-Ann Williams, BIVDA - as well as Caroline Cake, Health Data Research UK; Emily Crossley, Duchenne UK; and Professor Shanaya Rathod, Wessex Academic Health Sciences Network.


The agenda

  • Priorities for NICE and the policy landscape for health and social care;
  • Measuring the impact of NICE guidelines, utilising data, and improving patient and public engagement;
  • Challenges for accelerating the uptake of innovative medicines and medical technologies:
    • Future funding arrangements as NICE expands;
    • Shared decision-making, patient choice, and NHS collaboration with NICE;
    • Developing future guidelines and increasing adoption;
    • Priorities for the pharmaceutical industry - access, value, and improving outcomes; and
    • Evaluating health technologies - the role of HealthTech Connect.
  • Next steps for policy.

Engagement with policy officials at this conference

This Westminster Health Forum conference has attracted strong interest from policymakers. It will be an opportunity for stakeholders to engage with officials who have reserved places representing: Department of Health and Social Care; MHRA; the Office for Life Sciences; Government Legal Department; and the Department for International Trade.



Keynote Speaker

Professor Gillian Leng

Deputy Chief Executive and Director of Health and Social Care, NICE

Keynote Speakers

Professor Gillian Leng

Deputy Chief Executive and Director of Health and Social Care, NICE

Meindert Boysen

Director, Centre for Health Technology Evaluation, NICE

Chair

Anne Marie Morris MP

Speakers

Luella Trickett

Director, Value and Access, ABHI

Doris-Ann Williams

Chief Executive, BIVDA

Emily Crossley

Co-Founder and Joint Chief Executive Officer, Duchenne UK

Professor Shanaya Rathod

Consultant Psychiatrist and Director of Research, Southern Health NHS Foundation Trust; Visiting Professor, Faculty of Science, University of Portsmouth and Mental Health Clinical Lead, Wessex Clinical Research Network and Wessex Academic Health Sciences

Professor Andrew Briggs

Professor, Health Economics, Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine

Hilary Hutton-Squire

General Manager, UK and Ireland, Gilead

Dr Alan MacDonald

Chairman, Scottish Medicines Consortium and Consultant Rheumatologist, NHS Grampian

Professor Matthew Cripps

Director, Sustainable Healthcare, NHS England and NHS Improvement

Caroline Cake

Deputy Director and Chief Operating Officer, Health Data Research UK